Literature DB >> 3950802

Delayed use of hyperbaric oxygen for treatment of a model anterior compartment syndrome.

M B Strauss, A R Hargens, D H Gershuni, G B Hart, W H Akeson.   

Abstract

This study examines the effect of delayed exposure to hyperbaric oxygen on muscle necrosis and edema development following compartment syndromes in the canine hindlimb. Compartment syndromes (100 mm Hg for 8 h) were generated in one anterolateral compartment of six anesthetized dogs. After a 2-h delay, three 1-h hyperbaric oxygen treatments (2 atm absolute pure oxygen) were given during the next 12 h. Two days later, technetium-99m stannous pyrophosphate (99mTc Sn-PYP) was injected intravenously; 3 h later, samples were obtained from the pressurized and contralateral control muscles, weighed for edema development, counted for 99mTC Sn-PYP uptake, and evaluated histologically. Hyperbaric oxygen treatments, even when delayed 2 h, reduced muscle necrosis and intramuscular edema to negligible levels (p less than 0.05) compared with untreated animals. In addition, muscle morphology remained essentially normal in all hyperbaric oxygen-treated animals. We conclude that even if hyperbaric oxygen treatments are delayed 2 h, edema and muscle necrosis are reduced significantly in a model compartment syndrome.

Entities:  

Mesh:

Year:  1986        PMID: 3950802     DOI: 10.1002/jor.1100040114

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  3 in total

Review 1.  Hyperbaric oxygen therapy.

Authors:  Jayesh Shah
Journal:  J Am Col Certif Wound Spec       Date:  2010-04-24

2.  The effect of hyperbaric oxygen treatment on the inflammatory changes caused by intraperitoneal meconium.

Authors:  B Tokar; A H Gundogan; H Ilhan; K Bildirici; M Gultepe; E Elbuken
Journal:  Pediatr Surg Int       Date:  2003-10-18       Impact factor: 1.827

3.  Animal models in compartment syndrome: a review of existing literature.

Authors:  Dillon C O'Neill; Emily A Boes; Chance McCutcheon; Justin M Haller
Journal:  OTA Int       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.